Radelumin 200 - 4500 MBq/ml
As listed in the register: Radelumin 200 - 4500 MBq/ml, Injektionslösung
·
- Prescription only
- Everything that fits nowhere else, such as contrast media
- Active substance
- (18F)-PSMA-1007
- Made by
- Posimed Radiopharm AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- PET-Diagnose von PSMA-positivem Prostatakrebs
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Posimed Radiopharm AG |
|---|---|
| Active substance | (18F)-PSMA-1007 |
| Used in | Everything that fits nowhere else, such as contrast media |
| Classification | V09IX17 · Everything that fits nowhere else, such as contrast media |
| Dispensing (as stated by the register) | Abgabekategorie A |
| Name in the register | Radelumin 200 - 4500 MBq/ml, Injektionslösung |
| Packs | 15 ml |
| Zulassungsnummer | 67400 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.